22 May 2013
Keywords: mirtazepine, nears, approval, 1st, alpha2, blocker, antidepressant
Article | 30 October 1995
Organon's alpha2 receptor antagonist Remeron (mirtazepine) has been
recommended for approval in the USA for the treatment of patients with
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
30 October 1995
6 November 1995
21 May 2013
© 2013 thepharmaletter.com